Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in surgical patients with stage I-IV colorectal cancer (CRC).

被引：0
|
作者：
Cao, Di
Wang, Fu-Long
Li, Cong
Zhang, Rong-Xin
Wu, Xiao-Jun
Li, Liren
Lu, Zhen-Hai
Pan, Zhi-Zhong
Lin, Jun-zhong
Wu, Miaoqing
Liu, Yifan
Lv, Guangzhao
Li, Min
Wang, Chenyang
Li, Xi
Chen, Gong
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[2] Burning Rock Biotech, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
213
引用
收藏
页码：213 / 213
页数：1
相关论文
共 50 条
  • [31] Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patients
    Frydendahl, Amanda
    Nors, Jesper
    Rasmussen, Mads H.
    Henriksen, Tenna V.
    Nesic, Marijana
    Reinert, Thomas
    Afterman, Danielle
    Lauterman, Tomer
    Kuzman, Maja
    Gonzalez, Santiago
    Glavas, Dunja
    Smadback, James
    Maloney, Dillon
    Levativ, Jurica
    Yahalom, Michael
    Ptashkin, Ryan
    Tavassoly, Iman
    Donenhirsh, Zohar
    White, Eric
    Kandasamy, Ravi
    Alon, Ury
    Nordentoft, Iver
    Lindskrog, Sia V.
    Dyrskjot, Lars
    Jaensch, Claudia
    Love, Uffe S.
    Andersen, Per V.
    Thorlacius-Ussing, Ole
    Iversen, Lene H.
    Gotschalck, Kare A.
    Zviran, Asaf
    Oklander, Boris
    Andersen, Claus L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 211
  • [32] Use of circulating tumor DNA analysis to predict recurrence and need for adjuvant chemotherapy in stage I-IV colorectal cancer
    Li, Li-Ren
    Fan, Wenhua
    Xia, Zhiyuan
    Chen, Rongrong
    Lin, Dagui
    Li, Fang
    Zheng, Yang
    Luo, Jiongyong
    Xiong, Yuanyuan
    Yu, Pengli
    Gao, Wei
    Gong, Yuhua
    Zhang, Sen
    Zhang, Feiran
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Multimodal circulating tumor DNA (ctDNA) colorectal neoplasia detection assay for asymptomatic and early-stage colorectal cancer (CRC).
    Lee, Jeeyun
    Kim, Hee C.
    Kim, Seung Tae
    He, Yupeng
    Sample, Paul
    Nakamura, Yoshiaki
    Raymond, Victoria M.
    Jaimovich, Ariel
    Talasaz, AmirAli
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] INTERCEPT Program of circulating tumor DNA (ctDNA) testing for minimal residual disease (MRD) in colorectal cancer (CRC): Results from a prospective clinical cohort.
    Maddalena, Giulia
    Pellatt, Andrew Jared
    Eluri, Madhulika
    Parseghian, Christine Megerdichian
    Aziz, Kathryn
    Alfaro, Kristin
    Kell, Robert J.
    Bent, Alisha Heather
    Huey, Ryan W.
    Uppal, Abhineet
    Konishi, Tsuyoshi
    Overman, Michael J.
    Morelli, Maria Pia
    Willis, Jason
    Shen, John Paul Y. C.
    Raghav, Kanwal Pratap Singh
    Newhook, Timothy E.
    Morris, Van K.
    Dasari, Arvind
    Kopetz, Scott
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 27 - 27
  • [35] Circulating tumor DNA (ctDNA) detection of molecular residual disease (MRD) as a potential biomarker in localized soft tissue sarcoma (STS).
    Salawu, Abdulazeez
    Demicco, Elizabeth
    Chung, Peter W. M.
    Feeney, Jordan
    Lee, Jasmine
    Malone, Eoghan Ruadh
    Catton, Charles
    Arones, Limore
    Phillips, Madeline J.
    Wong, Philip
    Wunder, Jay
    Ferguson, Peter Charles
    Willingham, Stephen
    Shultz, David Benjamin
    Razak, Albiruni Ryan Abdul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer
    Abdalla, Thaer S. A.
    Meiners, Jan
    Riethdorf, Sabine
    Koenig, Alexandra
    Melling, Nathaniel
    Gorges, Tobias
    Karstens, Karl-F.
    Izbicki, Jakob R.
    Pantel, Klaus
    Reeh, Matthias
    [J]. PLOS ONE, 2021, 16 (06):
  • [37] Ultrasensitive circulating tumor DNA (ctDNA) minimal residual disease (MRD) detection in early stage non-small cell lung cancer (NSCLC)
    Isbell, James M.
    Goldstein, Jordan Scott
    Hamilton, Emily G.
    Liu, Si-Yang
    Eichholz, Jordan
    Buonocore, Darren J.
    Rusch, Valerie W.
    Bott, Matthew
    Molena, Daniela
    Rocco, Gaetano
    Yang, Soo-Ryum
    Rudin, Charles M.
    Jones, David R.
    Roff, Alanna
    Schultz, Andre
    Chabon, Jake J.
    Kurtz, David Matthew
    Alizadeh, Ash A.
    Li, Bob T.
    Diehn, Maximilian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Minimal residual disease (MRD) detection with circulating tumor DNA (ctDNA) from personalized assays in stage II-III colorectal cancer patients in a UK multicenter prospective study (TRACC)
    Anandappa, Gayathri
    Starling, Naureen
    Begum, Ruwaida
    Bryant, Annette
    Sharma, Shruti
    Renner, Derrick
    Aresu, Maria
    Peckitt, Clare
    Sethi, Himanshu
    Feber, Andrew
    Potter, Vanessa Alice
    Paraoan, Marius
    Abulafi, Muti
    George, Nicol
    Branagan, Graham
    Duff, Sarah
    West, Nicholas
    Aleshin, Alexey
    Chau, Ian
    Cunningham, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [39] Molecular residual disease detection with circulating tumor DNA analysis predicts relapse in patients with early stage breast cancer
    Turner, N.
    Garcia-Murillas, I.
    Chopra, N.
    Comino-Mendez, I.
    Beaney, M.
    Tovey, H.
    Cutts, R.
    Swift, C.
    Kriplani, D.
    Afentakis, M.
    Hrebien, S.
    Walsh, G.
    Johnston, S.
    Ring, A.
    Russell, S.
    Evans, A.
    Skene, A.
    Wheatley, D.
    Dowsett, M.
    Smith, I.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [40] Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation
    Mo, Shaobo
    Ye, Li
    Wang, Dongyang
    Han, Lingyu
    Zhou, Shuang
    Wang, Hui
    Dai, Weixing
    Wang, Yichao
    Luo, Wenqin
    Wang, Renjie
    Xu, Ye
    Cai, Sanjun
    Liu, Rui
    Wang, Zheng
    Cai, Guoxiang
    [J]. JAMA ONCOLOGY, 2023, 9 (06) : 770 - 778
12345